KIR3DL1 and colorectal carcinoma: In 2014, one of the first studies showed that KIR2DL5, KIR2DS5, KIR2DS1, and KIR3DS1 expression and KIR2DS4 and KIR3DL1 absence are associated with an increased risk of developing CRC [164].